Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host DNA polymerases, specifically the alpha (Pol α), delta (Pol δ), and epsilon (Pol ε) isoforms, are the fundamental enzymes responsible for replicating the eukaryotic genome during the S-phase of the cell cycle. Polyomaviruses, such as the BK virus and JC virus, possess small double-stranded DNA genomes that do not encode a viral DNA polymerase, making them entirely dependent on the host's replication machinery for viral progeny production (PubMed: 25135935). The viral Large T-antigen facilitates this hijacking by acting as a helicase and recruiting the host Pol α-primase complex to the viral origin of replication to initiate synthesis (UniProt: P03070). Subsequently, Pol δ and Pol ε are utilized for processive leading and lagging strand synthesis of the viral DNA. Because these enzymes are essential for host cell survival, they are difficult to target selectively; however, nucleotide analogs like cidofovir are used clinically to inhibit viral replication by interfering with the synthesis process (StatPearls: NBK545234). The primary therapeutic challenge lies in the fact that inhibiting these polymerases often results in significant systemic toxicity, such as nephrotoxicity and bone marrow suppression, due to the simultaneous inhibition of normal host DNA synthesis.
Inhibition of DNA chain elongation through competitive inhibition with natural deoxynucleotide triphosphates (dNTPs) or via DNA chain termination upon incorporation into the nascent DNA strand.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host DNA polymerases (DNA polymerase alpha, delta, and epsilon) (Pol α, Pol δ, Pol ε).